Retail Healthcare Sector

Annexon

Market Cap: US$220.5m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Amarin

Market Cap: US$219.1m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Rezolute

Market Cap: US$216.1m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Dimerix

Market Cap: AU$335.9m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Solid Biosciences

Market Cap: US$214.7m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Aardvark Therapeutics

Market Cap: US$214.6m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

Medical Facilities

Market Cap: CA$298.8m

Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.

Born

Market Cap: US$213.6m

Does not have significant operations.

Monash IVF Group

Market Cap: AU$331.2m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

OptimizeRx

Market Cap: US$211.4m

A digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients.

Tenax Therapeutics

Market Cap: US$211.2m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

AirSculpt Technologies

Market Cap: US$209.8m

Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

Integrated Diagnostics Holdings

Market Cap: US$209.3m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

Performant Healthcare

Market Cap: US$209.1m

Provides audit, recovery, and analytics services in the United States.

Tevogen Bio Holdings

Market Cap: US$207.8m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

BioStem Technologies

Market Cap: US$207.0m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Silence Therapeutics

Market Cap: US$206.4m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Actuate Therapeutics

Market Cap: US$206.1m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Codexis

Market Cap: US$204.6m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Prime Medicine

Market Cap: US$203.2m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

biote

Market Cap: US$201.0m

Operates in practice-building business within the hormone optimization space.

Design Therapeutics

Market Cap: US$199.3m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

SOPHiA GENETICS

Market Cap: US$197.8m

Operates as a cloud-native software technology company in the healthcare space.

Orthocell

Market Cap: AU$308.5m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

Perspective Therapeutics

Market Cap: US$195.2m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Lexicon Pharmaceuticals

Market Cap: US$194.4m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

OmniAb

Market Cap: US$193.3m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

ME Therapeutics Holdings

Market Cap: CA$269.8m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

High Tide

Market Cap: CA$269.5m

Engages in the cannabis retail business in Canada, the United States, and internationally.

4basebio

Market Cap: UK£144.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

Bioventix

Market Cap: UK£143.7m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

CARGO Therapeutics

Market Cap: US$190.0m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Fennec Pharmaceuticals

Market Cap: US$188.9m

Operates as a commercial stage biopharmaceutical company in the United States.

Omeros

Market Cap: US$188.4m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

ADC Therapeutics

Market Cap: US$187.4m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.